A Study of NeuroVaxâ„¢, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Inclusion Criteria:

Ages Eligible for Study: 18 Years to 70 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No Criteria
Subject is between 18 and 70 years of age, inclusive.
Definite MS by the revised McDonald criteria (2005) (Appendix A), with a Secondary Progressive course.
Expanded Disability Status Scale (EDSS) >=score 3.5 (Appendix B).
Two or more documented clinical relapses of MS in the preceding 24 months OR one documented clinical relapse of MS in the preceding 1 2 months prior to screening .
Laboratory values within the following limits:
Creatinine 1 . 5 x high normal.
Hemoglobin

Exclusion Criteria:

Subjects currently prescribed Campath or Lemtrada